Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004533 · ClinicalTrials.gov registry record
The Development and Evaluation of a Novel Duodenoscope Assessment Tool
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 745
- Enrollment target
NCT04004533: Completed study, sponsored by AdventHealth.
NCT04004533 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 745 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04004533 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 745 participants
- Enrollment target
Study Summary
Endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed using duodenoscopes for the treatment of pancreatic and biliary diseases. Although outcomes in endoscopic retrograde cholangiopancreatography (ERCP) procedures are measured mainly in terms of procedural success and complications, currently there are no objective tools to assess the technical performance of the duodenoscopes. The Center for Interventional Endoscopy has maintained a multicenter database that prospectively evaluates the technical performance of duodenoscopes for performing ERCPs. Our objective is to analyze the database in order to summarize the technical performance of duodenoscopes during ERCPs and evaluate the reliability of the duodenoscope assessment tool.
Primary Outcome
Assessment of the internal reliability of the duodenoscope assessment tool will be performed, as determined by the Cronbach's coefficient alpha
Interventions
- PROCEDURE Endoscopic retrograde cholangiopancreatography (ERCP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 745 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2021-12-31 |
What the finished NCT04004533 record still lists
NCT04004533 is an observational study that tracks outcomes without assigning an intervention. The registered 745 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic retrograde cholangiopancreatography (ERCP) is the first listed.
NCT04004533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04004533 about?
NCT04004533 is a clinical study titled "The Development and Evaluation of a Novel Duodenoscope Assessment Tool". Endoscopic retrograde cholangiopancreatography (ERCP) procedures are performed using duodenoscopes for the treatment of pancreatic and biliary diseases. Although outcomes in endoscopic retrograde cholangiopancreatography (ERCP) procedures are measured mainly in terms of procedural success and compli...
What is the current status of trial NCT04004533?
This trial is currently completed. The enrollment target is 745 participants. The study started on 2019-05-20. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04004533?
The interventions under investigation include: Endoscopic retrograde cholangiopancreatography (ERCP) (PROCEDURE).
Who is sponsoring clinical trial NCT04004533?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI